The effect of marine oil-derived n-3 fatty acids on transepithelial calcium transport in Caco-2 cell models of healthy and inflamed intestines

British Journal of Nutrition

Volumn 97, Issue 2, 2007, Pages 281-288

  Gilman, Jennifer ^a   Cashman, Kevin D ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Caco 2 cells; Calcium absorption; n 3 Fatty acids; Tumour necrosis factor

Indexed keywords

20:5 OMEGA 3 FATTY ACID; 22:6 OMEGA 3 FATTY ACID; CALCIUM; CALCIUM 45; FLUORESCEIN; INTERLEUKIN 8; LIPID; MARINE OIL; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DRUG EFFECT; DRUG SCREENING; ENTERITIS; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; MONOLAYER CULTURE;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CALCIUM; CELL SURVIVAL; CROHN DISEASE; ELECTRIC IMPEDANCE; FATTY ACIDS, OMEGA-3; HUMANS; INTERLEUKIN-8; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 34247619301     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507201758     Document Type: Article

References (41)

1. Arnaud SB, Goldsmith RS, Lambert PW & Go VL (1975) 25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 149, 570-572.
2. Belluzzi A (2002) n-3 Fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 61, 391-395.
3. Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR & Shanahan F (1996) A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 10, 777-786.
4. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I & Moniz C (1997) Reduced bone density in patients with inflammatory bowel disease. Gut 40, 228-233.
5. Cashman KD & Shanahan F (2003) Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol Hepatol 15, 607-613.
6. Coetzer H, Claassen N, van Papendorp DH & Kruger MC (1994) Calcium transport by isolated brush border and basolateral membrane vesicles: role of essential fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 50, 257-266.
7. Compston JE & Creamer B (1977) Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 18, 171-175.
8. Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F & Cashman KD (2004) Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am J Gastroenterol 99, 2178-2185.
9. Edmonson JM, Armstrong LS & Martinez AO (1988) A rapid and simple MTT-based assay for determining drug sensitivity in monolayer cultures. J Tissue Cult Methods 11, 15-17.
10. Endres S, Lorenz R & Loeschke K (1999) Lipid treatment of inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2, 117-120.
11. 3 in Caco-2 cells. Arch Biochem Biophys 308, 171-174.
12. 3-mediated regulation of transcellular calcium transport in Caco-2 cells. Am J Physiol 276, G958-G964.
13. Giuliano AR, Franceschi RT & Wood RJ (1991) Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285, 261-269.
14. Giuliano AR & Wood RJ (1991) Vitamin D-regulated calcium transport in Caco-2 cells: unique in vitro model. Am J Physiol 260, G207-G212.
15. Haag M & Kruger MC (2001) Upregulation of duodenal calcium absorption by poly-unsaturated fatty acids: events at the basolateral membrane. Med Hypotheses 56, 637-640.
16. Haag M, Magada ON, Claassen N, Bohmer LH & Kruger MC (2003) Omega-3 fatty acids modulate ATPases involved in duodenal Ca absorption. Prostaglandins Leukot Essent Fatty Acids 68, 423-429.
17. 2+-ATPase in basolateral membranes from rat enterocytes. Prostaglandins Leukot Essent Fatty Acids 61, 25-27.
18. Haderslev KV, Jeppesen PB, Sorensen HA, Mortensen PB & Staun M (2003) Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection. Gut 52, 653-658.
19. Jewell C & Cashman KD (2003) The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells. Br J Nutr 89, 639-647.
20. Jewell C, Cusack S & Cashman KD (2005) The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 72, 163-171.
21. Kennefick S & Cashman KD (2000) Investigation of an in vitro model for predicting the effect of food components on calcium availability from meals. Int J Food Sci Nutr 51, 45-54.
22. Kruger MC & Horrobin DF (1997) Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 36, 131-151.
23. Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, Bardan E, Hershkoviz R, Bar-Meir S & Chowers Y (2004) Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells. Clin Nutr 23, 1199-1208.
24. Lindmark T, Kimura Y & Artursson P (1998) Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 284, 362-369.
25. Ma TY, Boivin MA, Ye D, Pedram A & Said HM (2005) Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol 288, G422-G430.
26. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA & Said HM (2004) TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol 286, G367-G376.
27. Marano CW, Lewis SA, Garulacan LA, Soler AP & Mullin JM (1988) Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BEE, a human intestinal epithelial cell line. J Membr Biol 161, 263-274.
28. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
29. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L & Shanahan F (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118, 202-215.
30. Pinto M, Robine-Leon S, Appay MD, et al. (1983) Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47, 323-330.
31. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K & Rachmilewitz D (1998) Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 93, 1483-1490.
32. Ryan BM (2004) Effects of fatty acids on calcium uptake in an in vitro cell culture model. MSc Thesis, National University of Ireland, Cork.
33. Schmidt C, Kosche E, Baumeister B & Vetter H (1995) Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease. Eur J Gastroenterol Hepatol 7, 865-869.
34. Schoon EJ, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ & Stockbrugger RW (2001) Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut 48, 473-477.
35. Scott EM, Gaywood I & Scott BB (2000) Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut 46, S1-S8.
36. Silvennoinen J, Lamberg-Allardt C, Karkkainen M, Niemela S & Lehtola J (1996) Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 240, 285-292.
37. Snedecor GW & Cochran WG (1967) Statistical Methods. Ames, IA: Iowa State University Press.
38. Szulc P & Meunier PJ (2001) Is vitamin K defiency a risk factor for osteoporosis in Crohn's disease? Lancet 357, 1995-1996.
39. Tanaka Y, Taki Y, Sakane T, Nadai T, Sezaki H & Yamashita S (1995) Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum, and colon. Pharm Res 12, 523-528.
40. Watkins BA, Lippman HE, Le Bouteiller L, Li Y & Seifert MF (2001) Bioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res 40, 125-148.
41. Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharmacol Res 14, 763-766.